Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
MERRIMACK PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration | |||||||
| Equity | Common Stock, $0.01 par value per share | Other | 275,000(2) | $11.91(3) | $3,275,250 | $110.20 | $360.93 | |||||||
| Total Offering Amounts | $3,275,250 | $360.93 | ||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $360.93 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (the “Registration Statement”) shall also cover any additional shares of the common stock, $0.01 par value per share (the “Common Stock”), of Merrimack Pharmaceuticals, Inc. (the “Registrant”) that become issuable with respect to the securities identified in the above table, by reason of any stock dividend, stock splits, reverse stock splits, recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital adjustments effected without receipt of consideration that increases the number of outstanding shares of Common Stock. |
| (2) | Represents shares of Common Stock reserved for issuance under the 2021 Incentive Award Plan. |
| (3) | Estimated in accordance with Rules 457(c) and (h) of the Securities Act, solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $11.91 was computed by averaging the high and low prices of a share of the Registrant’s Common Stock as reported on The NASDAQ Stock Market on November 25, 2022. |